Clinical Trial Update: Evaluation of the Safety and the Ability of a DNA Vaccine to Protect Against Dengue Disease [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and potential protection against dengue fever using a DNA vaccine; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever

Drugs mentioned

• DNA vaccine (dengue) (DNA vaccine)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Dengue Disease, Dengue Fever | Phase 1 | Status: COMPLETED